GLLW
SUPN icon

Graves Light Lenhart Wealth’s Supernus Pharmaceuticals SUPN Stock Holding History

Graves Light Lenhart Wealth’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25
Closed -$1K – 770
2021
Q2 		$1K Buy
+25
New +$766 ﹤0.01% 710

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Graves Light Lenhart Wealth's SUPN Position: Q3 2021 in Review

Graves Light Lenhart Wealth sold out of Supernus Pharmaceuticals (SUPN) in Q3 2021, closing a stake of 25 shares — an estimated $1K sold.

Graves Light Lenhart Wealth first reported a position in SUPN in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 223 funds tracked by Wall St. Rank hold SUPN as of Q3 2021.

  • Graves Light Lenhart Wealth reported no remaining Supernus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 25 Supernus Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • Graves Light Lenhart Wealth first reported a position in Supernus Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • Graves Light Lenhart Wealth's Supernus Pharmaceuticals position peaked at $1K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2021.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2021, filed 15 Nov 2021.